We are live on ! Find out more
SOPH icon

SOPHiA GENETICS

34 hedge funds and large institutions have $70.4M invested in SOPHiA GENETICS in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

17% more funds holding

Funds holding: 2934 (+5)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.12% less ownership

Funds ownership: 33.89%33.77% (-0.12%)

58% less capital invested

Capital invested by funds: $167M → $70.4M (-$97.1M)

Holders
34
Holders Change
+5
Holders Change %
+17.24%
% of All Funds
0.57%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
10
Increased
8
Reduced
8
Closed
5
Calls
Puts
Net Calls
Net Calls Change

SOPH Hedge Fund Activity: Q2 2022 in Review

34 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q2 2022, worth a combined $70.4M — down 58% from $167M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SOPH positions and 5 closed out — a net gain of 5 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Alta Wealth Advisors, opening a new position worth an estimated $7.15M. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $4.53M sold.

  • 34 institutional investors held SOPHiA GENETICS (SOPH) as of Q2 2022, up from 29 in Q1 2022.
  • Funds reported $70.4M of SOPHiA GENETICS stock for Q2 2022, down 58% quarter-over-quarter.
  • 10 funds opened new SOPHiA GENETICS positions in Q2 2022 and 5 closed out, a net change of +5 holders.
  • The largest SOPHiA GENETICS buyer in Q2 2022 was Alta Wealth Advisors, an estimated $7.15M added.
  • The largest SOPHiA GENETICS seller in Q2 2022 was Pictet Asset Management (Switzerland), an estimated $4.53M sold.

Based on aggregated 13F filings for Q2 2022.